Marcela Maus

Person

Wynnewood, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
T cells expressing a chimeric antigen receptor
- Patent number 12,161,668
- Issue date Dec 10, 2024
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Molecular switch-mediated control of engineered cells
- Patent number 12,049,482
- Issue date Jul 30, 2024
- The Brigham & Women's Hospital, Inc.
- Max Jan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 11,865,167
- Issue date Jan 9, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions relating to ex vivo culture and modulation...
- Patent number 11,613,574
- Issue date Mar 28, 2023
- The General Hospital Corporation
- Marcela V. Maus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors based on alternative signal 1 domains
- Patent number 11,578,115
- Issue date Feb 14, 2023
- The General Hospital Corporation
- Marcela V. Maus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric antigen receptors targeting CD37
- Patent number 11,352,434
- Issue date Jun 7, 2022
- The General Hospital Corporation
- Marcela V. Maus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors having GITR intracellular domain as co-s...
- Patent number 11,332,513
- Issue date May 17, 2022
- ProMab Biotechnologies, Inc.
- Lijun Wu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,927,184
- Issue date Feb 23, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 10,308,717
- Issue date Jun 4, 2019
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using humanized anti-CD19 chimeric antigen rece...
- Patent number 10,221,245
- Issue date Mar 5, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activation and expansion of T-cells using an engineered multivalent...
- Patent number 9,453,199
- Issue date Sep 27, 2016
- The Trustees of the University of Pennsylvania
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...
- Patent number 9,394,368
- Issue date Jul 19, 2016
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activation and expansion of T-cells using an engineered multivalent...
- Patent number 8,637,307
- Issue date Jan 28, 2014
- The Trustees of the University of Pennsylvania
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activation and expansion of T-cells using an engineered multivalent...
- Patent number 7,745,140
- Issue date Jun 29, 2010
- The Trustees of the University of Pennsylvania
- Carl June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation and expansion of T-cells using an agent that provides a...
- Patent number 7,670,781
- Issue date Mar 2, 2010
- The Trustees of the University of Pennsylvania
- James Riley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation and expansion of T-cells using an engineered multivalent...
- Patent number 7,638,326
- Issue date Dec 29, 2009
- The Trustees of the University of Pennsylvania
- Carl June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activation and expansion of T-cells using an engineered multivalent...
- Patent number 7,638,325
- Issue date Dec 29, 2009
- The Trustees of the University of Pennsylvania
- Carl June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ANTI-MESOTHELIN CAR T CELLS SECRETING TEAMS AND METHODS OF USE THEREOF
- Publication number 20250000978
- Publication date Jan 2, 2025
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...
- Publication number 20240238396
- Publication date Jul 18, 2024
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT
- Publication number 20240075070
- Publication date Mar 7, 2024
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS RELATING TO EX VIVO CULTURE AND MODULATION...
- Publication number 20230322923
- Publication date Oct 12, 2023
- The General Hospital Corporation
- Marcela V. MAUS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS BASED ON ALTERNATIVE SIGNAL 1 DOMAINS
- Publication number 20230250150
- Publication date Aug 10, 2023
- The General Hospital Corporation
- Marcela V. MAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD37
- Publication number 20230167190
- Publication date Jun 1, 2023
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF
- Publication number 20230036569
- Publication date Feb 2, 2023
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD70 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES THEREOF
- Publication number 20220411478
- Publication date Dec 29, 2022
- The General Hospital Corporation
- Marcela V. Maus
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI
- Publication number 20220324964
- Publication date Oct 13, 2022
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T CELL TRANSCRIPTIONAL ATLAS
- Publication number 20220170097
- Publication date Jun 2, 2022
- THE BROAD INSTITUTE, INC.
- Angela Boroughs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD79B AND CD19
- Publication number 20220047636
- Publication date Feb 17, 2022
- The General Hospital Corporation
- Marcela V. Maus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED T CELLS AND METHODS OF THEIR USE
- Publication number 20210322473
- Publication date Oct 21, 2021
- The General Hospital Corporation
- Marcela V. Maus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...
- Publication number 20210284752
- Publication date Sep 16, 2021
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF T CELL MALIGNANCIES
- Publication number 20210277120
- Publication date Sep 9, 2021
- The General Hospital Corporation
- Marcela V. Maus
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19
- Publication number 20210268027
- Publication date Sep 2, 2021
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED T CELLS AND METHODS OF THEIR USE
- Publication number 20210137978
- Publication date May 13, 2021
- The General Hospital Corporation
- Marcela V. MAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210054086
- Publication date Feb 25, 2021
- The General Hospital Corporation
- Marcela V. MAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS
- Publication number 20210040166
- Publication date Feb 11, 2021
- The General Hospital Corporation
- Max Jan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT
- Publication number 20210038646
- Publication date Feb 11, 2021
- The General Hospital Corporation
- Marcela V. MAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS RELATING TO ENGINEERED REGULATORY T CELLS
- Publication number 20200330515
- Publication date Oct 22, 2020
- The General Hospital Corporation
- Marcela V. MAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200207852
- Publication date Jul 2, 2020
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE
- Publication number 20200164105
- Publication date May 28, 2020
- Massachusetts Institute of Technology
- Sangeeta N. BHATIA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT
- Publication number 20200113940
- Publication date Apr 16, 2020
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD37
- Publication number 20200079870
- Publication date Mar 12, 2020
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED T CELLS WITH CYTOTOXICITY TOWARD IMMUNOSUPPRESSIVE CELLS
- Publication number 20190345218
- Publication date Nov 14, 2019
- The General Hospital Corporation
- Marcela MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS RELATING TO EX VIVO CULTURE AND MODULATION...
- Publication number 20190330343
- Publication date Oct 31, 2019
- The General Hospital Corporation
- Marcela V. MAUS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS BASED ON ALTERNATIVE SIGNAL I DOMAINS
- Publication number 20190330302
- Publication date Oct 31, 2019
- The General Hospital Corporation
- Marcela V. MAUS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190328787
- Publication date Oct 31, 2019
- The General Hospital Corporation
- Marcela V. MAUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRVIII CHIMERIC ANTIGEN...
- Publication number 20190330356
- Publication date Oct 31, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY

Marcela Maus

Person

Patents Grantslast 30 patents

T cells expressing a chimeric antigen receptor

Molecular switch-mediated control of engineered cells

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Methods and compositions relating to ex vivo culture and modulation...

Chimeric antigen receptors based on alternative signal 1 domains

Chimeric antigen receptors targeting CD37

Chimeric antigen receptors having GITR intracellular domain as co-s...

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Treatment of cancer using humanized anti-CD19 chimeric antigen rece...

Activation and expansion of T-cells using an engineered multivalent...

Treatment of cancer using humanized anti-EGFRvIII chimeric antigen...

Activation and expansion of T-cells using an engineered multivalent...

Activation and expansion of T-cells using an engineered multivalent...

Activation and expansion of T-cells using an agent that provides a...

Activation and expansion of T-cells using an engineered multivalent...

Activation and expansion of T-cells using an engineered multivalent...

Patents Applicationslast 30 patents

ANTI-MESOTHELIN CAR T CELLS SECRETING TEAMS AND METHODS OF USE THEREOF

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN...

CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT

METHODS AND COMPOSITIONS RELATING TO EX VIVO CULTURE AND MODULATION...

CHIMERIC ANTIGEN RECEPTORS BASED ON ALTERNATIVE SIGNAL 1 DOMAINS

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37

ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF

CD70 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS AND USES THEREOF

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI

CAR T CELL TRANSCRIPTIONAL ATLAS

CHIMERIC ANTIGEN RECEPTORS TARGETING CD79B AND CD19

MODIFIED T CELLS AND METHODS OF THEIR USE

TREATMENT OF CANCER USING HUMANIZED ANTI-CD19 CHIMERIC ANTIGEN RECE...

COMPOSITIONS AND METHODS FOR TREATMENT OF T CELL MALIGNANCIES

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19

MODIFIED T CELLS AND METHODS OF THEIR USE

IMMUNE CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

MOLECULAR SWITCH-MEDIATED CONTROL OF ENGINEERED CELLS

CHIMERIC ANTIGEN RECEPTORS TARGETING THE TUMOR MICROENVIRONMENT

METHODS AND COMPOSITIONS RELATING TO ENGINEERED REGULATORY T CELLS

T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE

CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT

CHIMERIC ANTIGEN RECEPTORS TARGETING CD37

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

TARGETED T CELLS WITH CYTOTOXICITY TOWARD IMMUNOSUPPRESSIVE CELLS

METHODS AND COMPOSITIONS RELATING TO EX VIVO CULTURE AND MODULATION...

CHIMERIC ANTIGEN RECEPTORS BASED ON ALTERNATIVE SIGNAL I DOMAINS

T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRVIII CHIMERIC ANTIGEN...